Skip to main content

News Releases

AI at Case Western Reserve's digital-imaging lab advances understanding of which ‘stage 0’ patients are most likely to progress to advanced cancer and may benefit from additional therapy
New research at Case Western Reserve University could help better determine which patients diagnosed with the pre-malignant breast cancer commonly referred to as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery…
Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine announce program to advance discoveries by the next generation
Since its founding in 2012, Harrington Discovery Institute—part of The Harrington Project for Discovery & Development—has supported more than 100 drugs-in-the-making across disease areas and academic institutions. Core to its mission, Harrington Discovery Institute recognizes and supports inventive…
How do interactions between gut bacteria and fungi exacerbate Crohn’s disease?
Scientists have known that bacteria in the gut, along with environmental and genetic factors, contribute to the debilitating intestinal ailment of Crohn’s disease (CD). But in 2016, Mahmoud A Ghannoum, professor and director of the Center for Medical Mycology at Case Western Reserve University…
“Hike and Seek for Research” Event Benefits Pediatric Genetic Disorders
Take a hike! The third annual family- and dog-friendly Hike & Seek for Research will take place Sunday, September 15, at one of the award-winning Cleveland Metroparks, Brecksville Reservation. Guests can hike anytime between 10 a.m. and 2 p.m.   Upon check-in at Oak Grove Picnic Shelter, guests…
Swallowable Device to Detect Pre-cancerous Barrett's Esophagus Receives FDA 510(k) Clearance
Investigators at Case Western Reserve University School of Medicine, the Case Comprehensive Cancer Center and University Hospitals Cleveland Medical Center developed the test for early detection of Barrett’s esophagus that offers promise for preventing deaths from esophageal adenocarcinoma. The…
Obesity Pandemic Shifting Cancer to Younger People
A new study looking at incidence of disease data nationwide from 2000 to 2016 found a shift in obesity-associated cancers (OACs) to younger individuals. Typically, these cancers are diagnosed at higher rates among people older than 65. The most notable findings pertain to increases in these OACs…
Case Comprehensive Cancer Center Director Elected Senior Member of the National Academy of Inventors
The National Academy of Inventors (NAI) has named 54 academic inventors to the Spring 2019 class of NAI Senior Members, including Stanton L. Gerson, MD, Director of the Case Comprehensive Cancer Center (Case CCC). NAI Senior Members are active faculty, scientists and administrators from its Member…
A New Pathway: Researchers Identify Potential Treatment Target for Crohn’s Disease
There is no cure for the more than 1.6 million people in the United States living with Crohn’s disease (CD) and its symptoms, including abdominal pain, intestinal distress and severe weight-loss. CD is a form of inflammatory bowel disease (IBD) in which the body’s own immune system attacks the…
Case Western Reserve School of Medicine Scientist Receives Major Grant for Diagnosis of Alzheimer’s, Parkinson’s Via New Skin Test
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer’s disease, Parkinson’s disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive…
Researchers Discover New Combination Therapy to Treat Drug-Resistant Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia accounts for one in five adult leukemias, and is the most common pediatric cancer in the United States. While new immune therapies have helped improve survival rates, some patients are unresponsive to existing treatment regimens. In addition, drug-related toxicities and…